AU2001213481A1 - Synthetic regulatory compounds - Google Patents

Synthetic regulatory compounds

Info

Publication number
AU2001213481A1
AU2001213481A1 AU2001213481A AU1348101A AU2001213481A1 AU 2001213481 A1 AU2001213481 A1 AU 2001213481A1 AU 2001213481 A AU2001213481 A AU 2001213481A AU 1348101 A AU1348101 A AU 1348101A AU 2001213481 A1 AU2001213481 A1 AU 2001213481A1
Authority
AU
Australia
Prior art keywords
synthetic regulatory
regulatory compounds
compounds
synthetic
regulatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001213481A
Inventor
Aseem Ansari
Peter Dervan
Anna Mapp
Mark Ptashne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
California Institute of Technology CalTech
Memorial Sloan Kettering Cancer Center
Original Assignee
Sloan Kettering Institute for Cancer Research
California Institute of Technology CalTech
Memorial Sloan Kettering Cancer Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sloan Kettering Institute for Cancer Research, California Institute of Technology CalTech, Memorial Sloan Kettering Cancer Center filed Critical Sloan Kettering Institute for Cancer Research
Publication of AU2001213481A1 publication Critical patent/AU2001213481A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001213481A 2000-10-27 2000-10-27 Synthetic regulatory compounds Abandoned AU2001213481A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/029617 WO2002034295A1 (en) 2000-10-27 2000-10-27 Synthetic regulatory compounds

Publications (1)

Publication Number Publication Date
AU2001213481A1 true AU2001213481A1 (en) 2002-05-06

Family

ID=21741930

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001213481A Abandoned AU2001213481A1 (en) 2000-10-27 2000-10-27 Synthetic regulatory compounds

Country Status (2)

Country Link
AU (1) AU2001213481A1 (en)
WO (1) WO2002034295A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001279744A1 (en) * 2000-06-26 2002-01-08 Universite De Geneve Modulation of chromosome function by chromatin remodeling agents
WO2002031166A2 (en) * 2000-10-13 2002-04-18 Crosslink Genetics Corporation Artificial transcriptional factors and methods of use
WO2004113495A2 (en) 2003-05-23 2004-12-29 The President And Fellows Of Harvard College Rna-based transcriptional regulators
EP2199281A1 (en) * 2008-12-19 2010-06-23 DSM IP Assets B.V. Thioic acids as building block for polythioesters
CA3019342A1 (en) 2016-03-30 2017-10-05 Wisconsin Alumni Research Foundation Methods and compositions for modulating frataxin expression
WO2018183679A1 (en) 2017-03-29 2018-10-04 Wisconsin Alumni Research Foundation Methods and compositions for modulating gene expression

Also Published As

Publication number Publication date
WO2002034295A1 (en) 2002-05-02

Similar Documents

Publication Publication Date Title
AU2002225730A1 (en) Compounds
AU2002218266A1 (en) Novel indanylidene compounds
AU2001292518A1 (en) Novel compounds
AU2001248748A1 (en) Substituted piperazine compounds
AUPQ661800A0 (en) Insulin-potentiating compounds
AU2001239765A1 (en) Novel compounds
AU2001246998A1 (en) Novel compounds
AU2001253362A1 (en) Novel compounds
AU2002231077A1 (en) Novel compounds
AU2001238590A1 (en) Substituted piperazine compounds
AU2001288110A1 (en) Spiro compounds
AU2001256964A1 (en) Novel compounds
AU2002225724A1 (en) Motilide compounds
AU2405002A (en) Dehalogeno compounds
AU2002217285A1 (en) Compounds
AU2001230689A1 (en) Novel compounds
AU2001213481A1 (en) Synthetic regulatory compounds
AU2002216060A1 (en) Novel compounds
AU2002221923A1 (en) Novel compounds
AU2001276890A1 (en) Novel compounds
AU2001237533A1 (en) Novel p-gp-inhibiting compounds
AU2001258760A1 (en) Novel thiophenamide compounds
AU2002216043A1 (en) Compounds
AU2001232568A1 (en) Novel compounds
AU7634201A (en) 6-methyl-4-trihalomethyltriazine compounds